Unknown Cancer NIHR-supported project Brain & Nervous System
SNV1521-101 - A phase 1, open-label dose escalation and expansion study of SNV 1521 in participants with advanced solid tumors
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Michael Flynn (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors.
A Phase 1 Study of SGN-STNV in Advanced Solid Tumors
A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors
BNT326-01 - A Phase I/II, open-label, adaptive two-part trial to evaluate the safety, efficacy, optimal dose and pharmacokinetics of BNT326 as monotherapy and in combination with cancer immunotherapies in participants with advanced solid tumors
A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know